Biogen, Inc. (BIIB)

192.08 -2.05 (-1.06%) USD  |  NASDAQ  |  Feb 19, 16:00
190.92 -1.16 (-0.60%) After-Hours: 07:21
More

Biogen Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade